As before, we used Western blotting to profile the protein expression patterns of the AR and signaling molecules implicated in prostate cancer on a separate cohort of intact CNPC and vehicle and apalutamide-treated CRPC mice (n = 3 mice). The gene discussed is AR; the disease is prostate carcinoma.